IEB Pharma

WELCOME TO : IEB Pharma

Tagrix 80 mg, containing the active ingredient Osimertinib, is a groundbreaking medication used in the treatment of non-small cell lung cancer (NSCLC). Manufactured by IEB Pharma, Tagrix is specifically designed to target tumors with specific mutations in the epidermal growth factor receptor (EGFR) gene, notably the T790M mutation, which is associated with resistance to other EGFR inhibitors.




bus rental services
Webbaniya.com - B2B MarketPlace

Tagrix 80 mg, containing the active ingredient Osimertinib, is a groundbreaking medication used in the treatment of non-small cell lung cancer (NSCLC). Manufactured by IEB Pharma, Tagrix is specifically designed to target tumors with specific mutations in the epidermal growth factor receptor (EGFR) gene, notably the T790M mutation, which is associated with resistance to other EGFR inhibitors.



 

New Products / Services

  • blanks.jpg
    16 September

    Polo Tshirt

    Aire Select - Discover our exclusive collection of premium polo t-shirts for men. Explore a wide range of latest designs

    Tiruppur , India


Product Catagories




Full Name:
Company Name:
Country:
Email Address:
Tel / Mobile No.:
Website:
Please Explain: